Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Wall Street
Price Targets
Price Targets Summary
Guangzhou Wondfo Biotech Co Ltd
According to Wall Street analysts, the average 1-year price target for
Guangzhou Wondfo Biotech Co Ltd
is 38.73 CNY
with a low forecast of 38.33 CNY and a high forecast of 39.9 CNY.
Operating Income
Forecast
Operating Income Estimate
Guangzhou Wondfo Biotech Co Ltd
For the last 8 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's operating income is
41%.
The projected
CAGR
for the next 3 years is
-14%.
Net Income
Forecast
Net Income Estimate
Guangzhou Wondfo Biotech Co Ltd
For the last 8 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's net income is
37%.
The projected
CAGR
for the next 3 years is
-12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Guangzhou Wondfo Biotech Co Ltd's stock price target?
Price Target
38.73
CNY
According to Wall Street analysts, the average 1-year price target for
Guangzhou Wondfo Biotech Co Ltd
is 38.73 CNY
with a low forecast of 38.33 CNY and a high forecast of 39.9 CNY.
What is Guangzhou Wondfo Biotech Co Ltd's Revenue forecast?
Projected CAGR
-11%
For the last 8 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's revenue is
41%.
The projected
CAGR
for the next 3 years is
-11%.
What is Guangzhou Wondfo Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-14%
For the last 8 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's operating income is
41%.
The projected
CAGR
for the next 3 years is
-14%.
What is Guangzhou Wondfo Biotech Co Ltd's Net Income forecast?
Projected CAGR
-12%
For the last 8 years the
compound annual growth rate for
Guangzhou Wondfo Biotech Co Ltd's net income is
37%.
The projected
CAGR
for the next 3 years is
-12%.
You don't have any saved screeners yet
